🇺🇸 FDA
Pipeline program

Levothyroxine

2016-798

Approved small_molecule active

Quick answer

Levothyroxine for Heart Failure is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Heart Failure
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials